<p>Visit <a href="http://morningcommutepodcast.com/SGLT2inhibitors4" rel="nofollow">http://morningcommutepodcast.com/SGLT2inhibitors4</a> to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.</p>

Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.

<p>Visit <a href="http://morningcommutepodcast.com/SGLT2inhibitors4" rel="noopener noreferrer">http://morningcommutepodcast.com/SGLT2inhibitors4</a> to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.</p>

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Our @Point of Care Endocrinology Podcasts have healthcare experts discussing and providing information related to endocrinology diagnosis, treatment, management, and other important information.

Share S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Sign up to save your podcasts

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit